Cargando…
Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
Achieving high efficiency, targeted gene delivery with adenoviral vectors is a long-standing goal in the field of clinical gene therapy. To achieve this, platform vectors must combine efficient retargeting strategies with detargeting modifications to ablate native receptor binding (i.e. CAR/integrin...
Autores principales: | Coughlan, Lynda, Alba, Raul, Parker, Alan L., Bradshaw, Angela C., McNeish, Iain A., Nicklin, Stuart A., Baker, Andrew H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185574/ https://www.ncbi.nlm.nih.gov/pubmed/21994621 http://dx.doi.org/10.3390/v2102290 |
Ejemplares similares
-
Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy
por: Tessarollo, Nayara Gusmão, et al.
Publicado: (2021) -
Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective
por: JT, Schwartze, et al.
Publicado: (2022) -
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
por: Coughlan, Lynda
Publicado: (2020) -
Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses
por: Bradshaw, Angela C., et al.
Publicado: (2012) -
Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses
por: Kerstetter, Lucas J., et al.
Publicado: (2021)